BGI’s hereditary risk screening cancer panels target genes previously linked to a predisposition of cancer. Panel selection was based on expert curation of scientific literature and other high quality resources, including formal medical guidelines.
BGI’s Comprehensive Hereditary Cancer Panels provides information on 79 genes associated with 24 different types of hereditary cancer including some of the most commonly occurring cancers such as hereditary breast, ovarian, colorectal, pancreatic, prostate, and stomach cancer. BGI detects different alterations including germline SNV, Indels, and CNV.
Patients suspected of being at increased risk of hereditary cancer
14 - 26 days
Peripheral blood, DNA, Saliva
Target region capture, High-throughput sequencing
Ordering the BGI SENTIS™ Hereditary Cancer Screening is easy.
Physician orders test
Blood or saliva sample collected
Sample shipped to BGI and analyzed
Results sent to physician